Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Management Information Circular
View:
Post by toade1313 on May 29, 2024 8:00am

Management Information Circular

What did people learn from the Management Information Circular?
Comment by plantrader on May 29, 2024 8:50am
Aside from the typo that mentioned 2022 year end financials?
Comment by CAinPlap on May 29, 2024 9:57am
That too much of the PP's are going to executive compensation rather than treating patients. 
Comment by Lesalpes29 on May 29, 2024 10:09am
I only hope that we are close to positive news. When I Look to my warrants almost at zero, I'm feeling like a fool! GL
Comment by Alamir1111 on May 29, 2024 10:43am
LesalpesThat's OK. At east the money goes  in companys coffers 
Comment by Gooseybear on May 29, 2024 10:13am
Interesting that Roger is getting a big payday while all of his lieutenants are taking pay cuts. Also, changing auditors at the direction of the company can be a red flag as the former auditors may have given the company a worse opinion than they wanted. 
Comment by Alamir1111 on May 29, 2024 10:49am
Gooseybear good point about auditors if I recall correctly  that's about 3 in the last 5 years.i guess inflation and rising  fees 
Comment by plantrader on May 29, 2024 11:17am
Are you being serious, the company has changed auditing firms 3x in the past 5 years? I didn't know that, and I hope not. 
Comment by toade1313 on May 29, 2024 11:20am
Yes, enough Red Flags to think we were in China!!!
Comment by wildbird1 on May 29, 2024 11:41am
Gooseybear...sorry to disagree. There is also many good reasons why a company will change auditors. In this link...https://rsmus.com/insights/services/audit/five-considerations-for-switching-auditors.html 1) The company is growing and its need are changing. 2) The company is looking for a fresh take on technical issue. 3) The company needs deeper industry or business understanding. 4) The ...more  
Comment by plantrader on May 29, 2024 11:48am
You might make a good point. An external party could request they get a different auditing firm and have the financials re-reviewed or who knows what. Prior to something big happening. But 3x in 5 years? Has the company changed that much in the past 5 years?
Comment by Alamir1111 on May 29, 2024 11:55am
Check on cedar could be recycled from cedar to stockhouse https://stockhouse.com/companies/bullboard/tltff/theralase-technologies-inc?postid=35836841 https://www.biospace.com/article/releases/theralase-technologies-inc-announces-change-of-auditor-/
Comment by Alamir1111 on May 29, 2024 12:55pm
So the temporarily  appointed  auditor till this year's agm needs to be voted full tome I guess NOTICE IS HEREBY GIVEN that, on the advice of the Audit Commitee of Theralase Technologies Inc. (the “Corporation”), the Board of Directors of the Corporation resolved as of January 12, 2024, that: (i) the resignation of the Predecessor Auditor, with effect from January 12 ...more  
Comment by DeathXray33 on May 29, 2024 1:15pm
I voted "For" today. @ > 1.408 now.
Comment by Dumbeldorfwhite on May 29, 2024 3:07pm
We know, you re part of the good ole boys club. I mean with all those'd shares you d think you d want to make money.
Comment by Dumbeldorfwhite on May 29, 2024 3:14pm
Learned that this team doesn't know how to increase shareholder value
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250